Activation of the Aryl Hydrocarbon Receptor by TCDD Inhibits Mammary Tumor Metastasis in a Syngeneic Mouse Model of Breast Cancer

The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression

(2012) Timothy V. Beischlag et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Suppression of WIF-1 through promoter hypermethylation causes accelerated proliferation of the aryl hydrocarbon receptor (AHR) overexpressing MCF10AT1 breast cancer cells

(2011) Dalei Wu et al.   TOXICOLOGY

The aryl hydrocarbon receptor: fine-tuning the immune-response

(2010) Marc Veldhoen et al.   CURRENT OPINION IN IMMUNOLOGY

Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors

(2010) Tao Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist

(2010) Gérald J. Prud'homme et al.   PLoS One

Aryl Hydrocarbon Receptor Activation by TCDD Reduces Inflammation Associated with Crohn's Disease

(2010) Jenna M. Benson et al.   TOXICOLOGICAL SCIENCES

Tranilast inhibits the growth and metastasis of mammary carcinoma

(2009) Rabindranath Chakrabarti et al.   ANTI-CANCER DRUGS

The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice

(2009) Wayne A. Fritz et al.   BIOCHEMICAL PHARMACOLOGY

Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells

(2009) P. B. Olkhanud et al.   CANCER RESEARCH

The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy

(2009) Shu Zhang et al.   ENDOCRINE-RELATED CANCER

Oral Administration of 3,3′-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice

(2009) Eun Ji Kim et al.   JOURNAL OF NUTRITION

Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation

(2009) Julie M. Hall et al.   MOLECULAR ENDOCRINOLOGY

Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity

(2009) I. A. Murray et al.   MOLECULAR PHARMACOLOGY

AHR-mediated immunomodulation: The role of altered gene transcription

(2008) Nancy I. Kerkvliet   BIOCHEMICAL PHARMACOLOGY

Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound

(2008) B. P. Lawrence et al.   BLOOD

Imagable 4T1 model for the study of late stage breast cancer

(2008) Kai Tao et al.   BMC CANCER

A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1

(2008) Munehisa Takahashi et al.   CLINICAL & EXPERIMENTAL METASTASIS

TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells

(2008) Anja Seifert et al.   TOXICOLOGY LETTERS

The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor

(2007) Linh P. Nguyen et al.   CHEMICAL RESEARCH IN TOXICOLOGY